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INTRODUCTION:  Castleman’s  disease  (CD)  is a rare  disease  with  unknown  etiology  and  is  clinically  asso-
ciated  with  lymph  nodes  enlargement.  Primary  axillary  localization  of  CD  represents  2%  of  the  cases.  CD
rarely  occurs  in  the  breasts.
PRESENTATION OF  CASE:  We  herein  describe  a rare  case  of  CD  that  initially  presented  in the  breast  intra-
mammary  lymph  node  and  demonstrated  axillary  adenopathy.  Pathologic  analysis  showed  the  hyaline
vascular  form.  The  patient  underwent  axillary  lymphadenectomy.  The  natural  history  was  irregular
because  the  localized  CD progressed  to  a systemic  form  of CD.  At 4.6  years  of follow-up  a Hodgkin’s
lymphoma  appeared.astleman’s disease
ntramammary lymph node
xillary lymph nodes
odgkin’s  lymphoma
reast  neoplasia
DISCUSSION:  This  is  the  fourth  published  case of  localized  breast  CD published.  It is  important  to  evaluate
other  clinical  lymphadenopathies  at the time  of  diagnosis,  and  computed  tomography  is important  for
disease  evaluation  and  follow-up.
CONCLUSION: Patients  must  undergo  axillary  lymphadenectomy  when  showing  clinical  symptoms.
Irregular  progression  prompts  new  lymph  node  biopsy  because  of the  potential  presence  of associated
diseases.
gical © 2013 Sur
. Introduction
Castleman’s disease (CD) is a rare disease with unknown eti-
logy and is clinically associated with lymph node enlargement.1,2
ocalized breast CD is extremely rare. It is clinically related to intra-
ammary lymph node (ILN) disease or interpectoral lymph node
ith axillary adenopathy. Pathologic analysis of localized CD fre-
uently shows the hyaline vascular form.3–6
CD may  progress to a systemic form, the radiological aspects of
hich frequently comprise a local mass and regional or multiple
denopathy. The disease evolves aggressively, usually progressing
o death, secondary to infection or a second neoplasia, resistant to
orticosteroids and chemotherapy.2
Radiographic signs of CD are not speciﬁc and are frequently
elated to a mass or adenopathy. Because of the absence of spe-
iﬁc symptoms or signs and the potential for development into
he systemic form, computed tomography (CT) is important for
linical evaluation, treatment planning, and follow-up.7 Irregular
rogression must undergo pathological conﬁrmation because of
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the potential presence of associated diseases. We herein present
the fourth published case of localized breast CD. This report illus-
trates a case of breast localized CD that progressed to a systemic
form and subsequent Hodgkin’s lymphoma.
2. Presentation of case
A 49-year-old female patient presented with a 2-year history
of a right-sided axillary lymph node growth. On examination,
axillary adenopathy and breast nodulation were noted. Mam-
mography showed only slight bulging with a soft-tissue density
in the right axillary region next to the pectoralis major muscle
(which coincided with the clinical complaint). Ultrasound revealed
well-deﬁned rounded, solid nodules in the right axilla with a hyper-
ﬂux pattern on Doppler examination, which was compatible with
increased lymph node size, although nonspeciﬁc (Fig. 1). Resection
of the breast lymph node showed angiofollicular hyperplasia,
also known as giant lymphoid hyperplasia or CD of the hyaline-
vascular form (CD/HVF) (Fig. 3). Hypergammaglobulinemia was
not observed, and an HIV serological test was negative. Thoracic
and abdominal CT showed absence of other lymphadenopathy. The
patient underwent axillary dissection, which conﬁrmed the diag-
Open access under CC BY-NC-ND license.nosis of CD/HVF.
Three  months later, supraclavicular adenopathy appeared. Eight
monthly cycles of prednisone were then administered, and the
patient remained asymptomatic for 18 months. Because of the
NC-ND license.
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Fig. 1. Mammographic and ultrasonographic ﬁndings. (a) Mammography, mediolateral oblique view. The arrow shows asymmetry related to intramammary lymph nodes;
(b)  mammography. Spot located in the axilla. The arrow shows a bulge over the pectoral muscle. (c) Ultrasound using a high frequency linear probe. Right axillary lym-
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ihadenopathy is seen, characterized by at least three well-deﬁned, rounded, hypoe
nd  (d) Color Doppler. Central and peripheral hyperﬂux can be seen.
eappearance of the supraclavicular disease and left axillary symp-
omatic disease, the patient was submitted to CT with contrast. This
onﬁrmed the presence of increased numbers of multiple small,
igh-uptake mediastinal lymph nodes in the paratracheal and pre-
racheal regions and left axilla (Fig. 2). The patient then underwent
eft axillary lymphadenectomy; pathologic examination showed
D/HVF, and prednisone was reintroduced, which helped to sta-
ilize the patient’s condition.
ig. 2. Computed tomography ﬁndings at 18 months after diagnosis. (a) Axial slices of the 
ncreased and moderately increased paratracheal and pretracheal lymph nodes in the lefnic solid nodules with loss of the usual adipose hilum (increased lymph node size)
After 4.6 years of follow-up, lymph nodes reappeared in the
right supraclavicular fossa. A biopsy taken from this region showed
the presence of nodular lymphocyte predominant Hodgkin’s lym-
phoma (Fig. 3). The patient underwent adriamycin, bleomycin,
vinblastine and dacarbazine (ABVD) chemotherapy and mini-
mantle radiotherapy with a boost in the fossa and in the cervical
region. A favorable result was obtained. Currently, 12.9 years after
the onset of this condition, the patient is alive and disease-free.
supra-aortic mediastinal region and (b) Prevascular space. The arrow shows slightly
t axillary region.
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cig. 3. Pathologic ﬁndings. (a) Histology of the hyaline-vascular form. HE, 40×:  lymp
c)  Hodgkin’s lymphoma. HE, 400×. (d) Negativity for CD30. (e) Negativity for CD15
y  CD3+ T cells and (h) Arrow shows neoplastic cells surrounded by CD57+ T cells.
. Discussion
CD or angiofollicular giant lymph node hyperplasia is a rare,
enign condition that was ﬁrst described in 1956 in patients
ith single mediastinal lymph node adenopathy.1,2 This was  later
elated to lymph node involvement in multiple groups.1,2 CD ori-
inates in the lymphoid tissue. The etiology and pathogenesis are
nknown but an immunoregulatory abnormality is implicated in
ts development.2,3 Differential diagnoses may  include lymphoid
eoplasms, inﬂammatory reactions and metastatic disease.3,8 Pri-
ary axillary localization of CD represents 2% of the cases3,8,9 and
D is rare in the breasts.3–6,10
CD is clinically divided into localized or systemic forms and
istologically into the hyaline-vascular, plasmacytic subtypes or
ixed subtypes.1,2,11 Although extremely rare, the appearance of
ocalized CD in the breast is related to interpectoral lymph nodes4
r ILNs with frequent involvement of axillary nodes5 or lymphoid
issue in the subcutaneous mammary tissue.4–6 To the best of our
nowledge, it is the fourth published case4–6 of localized CD form
n the breast.
By deﬁnition, ILNs are surrounded by breast tissue.12 They are
linically and mammographically occult in 37% of patients ande with lymphoid cells in an “onion skin” pattern with a hyaline center. (b) HE, 200×.
ypical cells immunoexpressing CD20. (g) Arrow shows neoplastic cells surrounded
appear as a solid hypoechoic mass of indeterminate etiology in
12%.13 Discovered as a nonpathological lump on mammography,
frequently in the upper-outer quadrant, their detection does not
require further diagnostic investigation, unless enlargement of the
mass is seen on a subsequent mammographic examination. A size
of less than 10 mm14 or 15 mm15 was  initially considered to be
normal, but their density, replacement of central fat, and shaggy
margins are more important signs to investigate.14 On sonographic
examination, when the echogenic hilum is absent, a metastatic
ILN displays a completely hypoechoic echotexture.12,13 Associated
with a round shape and well-delineated margins, it may mimic a
benign mass and resemble a synchronous benign-appearing breast
nodule in a patient with breast cancer.12 If the ﬁndings are suspi-
cious the lymph node should be biopsied.13 The main differential
diagnoses are inﬂammation, reaction to dermatitis, tuberculosis,
lymphoproliferative disease, and breast cancer.15 Chang et al. pub-
lished a case report of a ductal carcinoma in situ with microinvasion
associated with a synchronous CD in the axilla, mimicking axillary
metastasis.10
In the present case, CD was  present in a breast ILN in the mam-
mary tail of Spence with axillary adenopathy. ILN and axillary CD
disease should therefore be included as a differential diagnosis
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f axillary adenopathy. Radiographic signs of CD are nonspeciﬁc
nd are frequently related to a mass or adenopathy. Mammogra-
hy can show any lesion,4 a nodular area with irregular margins
ithout microcalciﬁcations,5 or just axillary adenopathy (Fig. 1).
ltrasound shows a hypoechoic mass5 with hyperechoic regions16
r lymphadenopathy.5,10 Color Doppler sonography shows an
rtery penetrating the hilum of the mass and ﬁne accessory
eripheral arteries,16 an unclear lymph-like morphology with an
rregular vascular pattern,5 or loss of the usual adipose hilum
Fig. 1).
The localized form of CD is generally asymptomatic, with clinical
anifestations secondary to the tumor growth. The hyaline-
ascular form is the most frequently observed type of localized CD.
t occurs in 76–91% of patients with localized disease, and the differ-
ntial diagnoses include adenopathies of other origins.11 The sites
nvolved are overwhelmingly nodal, and the mediastinum and cer-
ical regions accounting for 73% of the cases.2 The treatment for
he localized disease comprises of complete resection of the lesion,
hich results in improvement of the symptoms and a cure in most
ases.2,17 For localized and unresectable disease, radiotherapy and
orticoids can be used.1,2,17
In such cases, local resection allows for initial control of the CD,
s described in our patient,5 but the disease progresses to a sys-
emic form with the appearance of lymphadenopathy at multiple
ites. On CT, the disease appears as a homogeneous16 or heteroge-
eous soft-tissue-attenuating masses, that can be associated with
ymphadenopathy18 or just a lymphadenopathy (Fig. 3). Enhance-
ent after the intravenous administration of contrast material is
requent.18 The CT is important for treatment planning and follow
p.7
The systemic form is frequently associated with plasmocitary
istological ﬁndings and systemic symptoms. Clinically charac-
erized by multiple adenopathies resistant to corticosteroids and
hemotherapy. The disease evolves aggressively, usually result-
ng in death secondary to infection or a second neoplasia.2,11
here are associations with second primary tumors such as lym-
homa and sarcoma.11 There is no speciﬁc treatment; patients
re treated with corticosteroids, chemotherapy, and interferon,
nd the results are unpredictable.17 The present case was treated
ith corticosteroids and chemotherapy with partial control of the
D.
The unfavorable clinical progression with increased severity
f lymphadenopathy led to a subsequent diagnosis of Hodgkin’s
ymphoma, which is an extremely rare condition.19 The clinical
rogression prompted us to perform a new histological evaluation,
nd the patient’s disease was controlled. Non-Hodgkin’s lymphoma
ay  occur in 18% of patients with systemic CD,20 while Hodgkin’s
ymphoma occurs less frequently17 and has been associated with
he multicentric plasma-cell variant of CD.19
Patients must be followed up carefully because of the potential
or irregular progression. CD is associated with signiﬁcant morbid-
ty and mortality. The cause of death is usually directly related to
he disorder itself, infectious complications, or a second primary
eoplasia.2
. Conclusion
Breast CD disease is a rare disease, and when it occurs in the
reast, it appears in the ILN. It is important to evaluate other clini-
al lymphadenopathies at the time of diagnosis and CT is important
or diagnosis and follow-up. Patients with clinically symptomatic
isease must undergo lymphadenectomy. Irregular progression
hould be assessed with new lymph node biopsies because of the
otential for Hodgkin’s lymphoma and non-Hodgkin’s lymphoma,
hich can have the same clinical appearance.
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